Day 1 Full Agenda
Monday, May 4, 2026
Welcome and Opening Remarks
Laura Lubbers, PhD, CURE Epilepsy
Mechanism of PTE in Preclinical Studies (Preclinical Session, part 1)
Introduction: John Wolf, Session Moderator
Kevin Staley, Massachusetts General Hospital
Jeanne Paz, Gladstone Institute, UCSF, San Francisco, California
Chris Dulla, Tufts University, Boston, Massachusetts
Early-Stage Investigator (from abstract submissions)
10:00 AM - Break
Mechanism of PTE in Preclinical Studies (Preclinical Session, part 2)
Introduction: Chris Dulla, Session Moderator
John Wolf, University of Pennsylvania, Philadelphia, Pennsylvania
Michelle Olsen, Virginia Tech University, Roanoke, Virginia
Elisa Zanier, Mario Negri Institute, Milan, Italy
Aylin Ried, University of Toronto, Toronto, Canada
Discussion: Post-Traumatic Epilepsy: The Lived Experience
12:00 PM - Lunch and Poster Session
Mechanisms of PTE in Pre-Clinical Studies (Lessons from EpiBios4Rx-Preclinical)
Introduction: Elisa Zanier, Session Moderator
Paul Vespa, UCLA, Los Angeles, CA
Asla Pitkanen, University of Eastern Finland, Kuopio, Finland
Aristea Galanopoulou, Albert Einstein College of Medicine, NY
Early-Stage Investigator (from abstract submissions)
3:55 PM - Break
Discussion and Wrap-up of Day 1: What are the most promising mechanisms to target for anti-epileptogenic therapies? What are the most promising animal models?
Moderator and Discussants: Asla Pitkanen, John Wolf, Aristea Galanopoulou